NO20084865L - Behandling av smertelidelser med trans 4-(3,4-diklorfenyl)-1, 2, 3,4-tetrahydro-1-nafthalenamin og dens formamid - Google Patents

Behandling av smertelidelser med trans 4-(3,4-diklorfenyl)-1, 2, 3,4-tetrahydro-1-nafthalenamin og dens formamid

Info

Publication number
NO20084865L
NO20084865L NO20084865A NO20084865A NO20084865L NO 20084865 L NO20084865 L NO 20084865L NO 20084865 A NO20084865 A NO 20084865A NO 20084865 A NO20084865 A NO 20084865A NO 20084865 L NO20084865 L NO 20084865L
Authority
NO
Norway
Prior art keywords
dichlorophenyl
naphthalenamine
tetrahydro
trans
treatment
Prior art date
Application number
NO20084865A
Other languages
English (en)
Inventor
Larry R Bush
Paul Tarantino
Una Campbell
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Publication of NO20084865L publication Critical patent/NO20084865L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)

Abstract

Behandling av smertelidelser med (1R,4S)-trans-4-(3,4-diklorfenyl)-1,2,3,4-tetrahydro-1-naftalenamin og (1S,4R)-trans-4-(3,4-diklorfenyl)-1,2,3,4-tetrahydro-1-naftalenamin er beskrevet. En fremgangsmåte for fremstilling av 4-(3,4-diklorfenyl)-1,2,3,4-tetrahydro-1-naftalenamin er også beskrevet. Fremgangsmåten omfatter fremstilling av alle fire isomerer av N-[4-(3,4-diklorfenyl)-1,2,3,4-tetrahydronaftalen-1-yl]formamid, som også er anvendelige i behandling av smertelidelser.
NO20084865A 2006-05-31 2008-11-19 Behandling av smertelidelser med trans 4-(3,4-diklorfenyl)-1, 2, 3,4-tetrahydro-1-nafthalenamin og dens formamid NO20084865L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80964906P 2006-05-31 2006-05-31
PCT/US2007/065585 WO2007143267A2 (en) 2006-05-31 2007-03-30 Treatment of pain disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine and its formamide

Publications (1)

Publication Number Publication Date
NO20084865L true NO20084865L (no) 2008-12-19

Family

ID=38802161

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20084865A NO20084865L (no) 2006-05-31 2008-11-19 Behandling av smertelidelser med trans 4-(3,4-diklorfenyl)-1, 2, 3,4-tetrahydro-1-nafthalenamin og dens formamid

Country Status (13)

Country Link
US (1) US20070282007A1 (no)
EP (1) EP2043745A2 (no)
JP (1) JP2009538925A (no)
KR (1) KR20090015089A (no)
CN (1) CN101484210A (no)
AU (1) AU2007254751A1 (no)
BR (1) BRPI0712744A2 (no)
CA (1) CA2653498A1 (no)
IL (1) IL195441A0 (no)
MX (1) MX2008015048A (no)
NO (1) NO20084865L (no)
RU (1) RU2008152404A (no)
WO (1) WO2007143267A2 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8134029B2 (en) * 2002-09-16 2012-03-13 Sunovion Pharmaceuticals Inc. Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
JP2009500425A (ja) 2005-07-06 2009-01-08 セプラコア インコーポレーテッド エスゾピクロン及びトランス４−（３，４−ジクロロフェニル）−１，２，３，４−テトラヒドロ−ｎ−メチル−１−ナフタレンアミン又はトランス４−（３，４−ジクロロフェニル）−１，２，３，４−テトラヒドロ−１−ナフタレンアミンの組み合わせ、並びに閉経期並びに気分、不安、及び認知障害の治療方法
DK2816024T3 (en) 2006-03-31 2017-10-30 Sunovion Pharmaceuticals Inc CHIRALE AMINER
JP2012526832A (ja) * 2009-05-13 2012-11-01 スノビオン プハルマセウトイカルス インコーポレイテッド トランスノルセルトラリン及びセロトニン受容体１ａ作動剤／拮抗剤を含む組成物及びその使用
NZ600107A (en) * 2009-12-04 2014-10-31 Sunovion Pharmaceuticals Inc Formulations, salts and polymorphs of transnorsertraline and uses thereof
EA025500B1 (ru) * 2012-02-03 2016-12-30 Грюненталь Гмбх (1R,4R)-6'-ФТОР-(N-МЕТИЛ- ИЛИ N,N-ДИМЕТИЛ-)-4-ФЕНИЛ-4',9'-ДИГИДРО-3'Н-СПИРО[ЦИКЛОГЕКСАН-1,1'-ПИРАНО[3,4,b]ИНДОЛ]-4-АМИН ДЛЯ ЛЕЧЕНИЯ ФИБРОМИАЛГИИ И СИНДРОМА ХРОНИЧЕСКОЙ УСТАЛОСТИ
KR101599399B1 (ko) 2015-02-23 2016-03-03 (주)두올상사 친환경 폴리우레탄 스킨 원단 및 그 제조방법
JP2021512057A (ja) * 2018-01-19 2021-05-13 サノビオン ファーマシューティカルズ インクＳｕｎｏｖｉｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． 経口製剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556676A (en) * 1979-11-01 1985-12-03 Pfizer Inc. Antidepressant derivatives of trans-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
US4981870A (en) * 1989-03-07 1991-01-01 Pfizer Inc. Use of 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine derivatives in the treatment of psychosis, inflammation and as immunosuppressants
US5554383A (en) * 1995-04-06 1996-09-10 Trustees Of Tufts College Veterinary method for clinically modifying the behavior of dogs exhibiting canine affective aggression
GB9617990D0 (en) * 1996-08-29 1996-10-09 Scotia Holdings Plc Treatment of pain
US5778986A (en) * 1997-08-05 1998-07-14 Davis; Floyd A. Device to remove divots
GB9904786D0 (en) * 1999-03-02 1999-04-28 Merck Sharp & Dohme Therapeutic agents
US6245782B1 (en) * 1999-05-17 2001-06-12 Heartdrug Research L.L.C. Methods of inhibiting platelet activation with selective serotonin reuptake inhibitors
JP4610336B2 (ja) * 2002-09-16 2011-01-12 セプラコール インク． トランス４−（３，４−ジクロロフェニル）−１，２，３，４−テトラヒドロ−１−ナフタレンアミン及びそのホルムアミドによる中枢神経系障害の治療

Also Published As

Publication number Publication date
EP2043745A2 (en) 2009-04-08
IL195441A0 (en) 2009-08-03
CA2653498A1 (en) 2007-12-13
RU2008152404A (ru) 2010-07-10
BRPI0712744A2 (pt) 2012-09-25
KR20090015089A (ko) 2009-02-11
JP2009538925A (ja) 2009-11-12
MX2008015048A (es) 2008-12-10
US20070282007A1 (en) 2007-12-06
AU2007254751A1 (en) 2007-12-13
CN101484210A (zh) 2009-07-15
WO2007143267A3 (en) 2008-12-04
WO2007143267A2 (en) 2007-12-13

Similar Documents

Publication Publication Date Title
NO20084865L (no) Behandling av smertelidelser med trans 4-(3,4-diklorfenyl)-1, 2, 3,4-tetrahydro-1-nafthalenamin og dens formamid
EA200870471A1 (ru) Замещенные пирролидиноны в качестве ингибиторов 11-бета-гидроксистероиддегидрогеназы 1 типа
NO20050074L (no) Modulatorer for glukocorticoidreseptoren og metode
NO20161634A1 (no) 3-Z-[1-(4-(N-((4-metyl-piperazin-1-yl)-metylkarbonyl)-N-metyl-amino)-anilino)-1-fenyl-metylen]-6-metoksykarbonyl-2-indolinon, tautomerene, diastereomerene, enantiomerene, blandinger derav og saltene derav, og i kombinasjon med en ytterligere farmakologisk aktiv substans, for anvendelse i forebygging eller behandling av fibrose ved revmatoid artritt
NO20082447L (no) Biaryl-meta-pyrimidininhibitorer av kinaser, eller farmasøytisk akseptable salter, hydrater, solvater, krystallformer, N-oksider og individuelle diastereomerer derav, farmasøytisk sammensetning derav, samt anvendelser derav for behandling av forstyrrelser.
NO20082026L (no) Deazapuriner som er nyttige som inhibitorer for Janus-kinaser
NO20084318L (no) Inhibitorer av II-beta-hydroksystereoid dehydrogenase I
ATE471311T1 (de) Inhibitoren von11-beta- hydroxysteroiddehydrogenase 1
BRPI0314377B8 (pt) composto, composição farmacêutica, tablete ou cápsula, uso de uma quantidade terapeuticamente eficaz, e, processo para preparar um composto
NO20084403L (no) Cykloheksylpyrazol-lactamderivater som inhibitorer av II-beta-hydroksysteroid dehydrogenase I
IL213425A0 (en) Adamantyl derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase
WO2007084667A3 (en) Fused heterobicyclic kinase inhibitors
NO20082673L (no) Nye 2-amino-imidazol-4-on forbindelser og deres anvendelse i fremstilling av et medikament som skal brukes til behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerasjon og demens
TNSN07048A1 (en) Trifluoromethyl substituted benzamides as kinase inhibitors
NO20091700L (no) Florizinanaloger som inhibitorer av glukose-ko-transporter 2
PL2049475T3 (pl) Pirolidynony podstawione cykloheksylem jako inhibitory 11-betahydrokysterydu dehydrogenazy 1
MA29742B1 (fr) Derives de benzoquinazoline et utilisation de ceux-ci dans le traitement de maladies osseuses
NO20063620L (no) Arylanilinderivater som beta2 adrenergiske receptoragonister
MX2009010127A (es) Compuestos utiles como inhibidores de janus cinasas.
PH12021553202A1 (en) Analogues of 3-(5-methyl-1,3-thiazol-2-yl)-n-{(1r)-1-[2-(trifluoro-methyl)pyrimidin-5-yl]ethyl}benzamide
NO20073760L (no) Triazolon-, tetrazolon- og imidazolonderivater for anvendelse som alfa-2C-adrenoreseptorantagonister
MX2022004878A (es) Derivados de n-(heteroaril)quinazolin-2-amina a manera de inhibidores de lrrk2, composiciones farmaceuticas y usos de los mismos.
MX2024013950A (es) Derivado de hidroxiamida y uso del mismo
NO20091969L (no) N-(2-hydroksyetyl)-N-metyl-4-(quinolin-8-yl(1-(tiazol-4-ylmetyl)piperidin-4-yliden)metyl)benzamid, fremgangsmate for fremstilling av den sa vel som dens anvendelse for behandling av smerte, angst og depresjon
WO2004052858A3 (en) Inhibitors of monoamine uptake

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application